Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis
Clinical trial NCT03010228 · COMPLETED
Trial details
- NCT number
- NCT03010228
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2017-09-28
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.